Trial Comparing Treatment With SInergy™ System to Conservative Treatment for Chronic Sacroiliac Joint Pain
TerminatedNot applicableNCT01158092
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to evaluate the effectiveness of cooled radiofrequency denervation of the sacroiliac region using the SInergy System compared to conservative treatment in the treatment of sacroiliac joint pain.
Study details
- Official title
- A Randomized Controlled Trial Comparing Cooled Radiofrequency Denervation to Conservative Treatment as a Treatment for Sacroiliac Joint Pain Using the SInergy™ System
- Conditions
- Chronic Sacroiliac Joint Pain
- Interventions
- Device: Treatment with SInergy™ System
- Other: Conservative Treatment
- Sponsor
- Baylis Medical Company
- Start date
- 2010-07
- Primary completion
- 2012-03
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Predominantly axial pain below the L5 vertebrae * \>75% pain relief from 2 separate lateral branch blocks done on different days (followed by return to baseline pain) * Chronic axial pain lasting for longer than six months: 3 day average VAS between 4 and 8. * Age greater than 18 years. * Failed to achieve adequate improvement with comprehensive non-operative treatments, including but not limited to: activity alteration, non-steroidal anti-inflammatory, physical and/or manual therapy, and fluoroscopically guided steroid injections in and around the area of pathology. * All other possible sources of low back pain have been ruled out, including but not limited to: the intervertebral discs, bone fracture, the zygapophyseal joints, the hip joint, symptomatic spondylolisthesis, tumor and other regional soft tissue structures (this is done by physical exam, medical history, and MRI/CT/X-ray as required) Exclusion Criteria: * Beck Depression Score \>20 or irreversible psychological barriers to recovery * Spinal pathology that may impede recovery such as spina bifida occulta, spondylolisthesis at L5/S1, or scoliosis. * Moderate or severe foraminal or central canal stenosis * Systemic infection or localized infection at anticipated introducer entry site. * Concomitant cervical or thoracic pain greater than 2/10 on a VAS * Uncontrolled or acute illness * Chronic severe conditions such as rheumatoid/inflammatory arthritis * Pregnancy * Active radicular pain * Immunosuppression (eg. AIDS, cancer, diabetes, surgery \<3 months ago) * Worker's compensation, injury litigation, or disability remuneration * Allergy to injectants or medications used in procedure * High narcotics use (\>30 mg hydrocodone or equivalent) * Patients who smoke. Termination for at least 6 months and no smoking during follow up period are acceptable with caution. * Body Mass Index greater than 29.9 (obese). * Subject unwilling to consent to the study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01158092